Research Assistant
Search across all peptide monographs, dosing protocols, and clinical articles. Type a keyword to find relevant information instantly.
132 items available — type to search
AOD-9604
Growth Hormone Fragment - Fat Metabolism Guide
BPC-157
Body Protection Compound - Complete Clinical Guide
CJC-1295/Ipamorelin
Growth Hormone Secretagogue Combination - Prescriber Guide
Epithalon
Telomerase Activator Peptide - Anti-Aging Guide
GHK-Cu
Copper Peptide Complex - Regenerative Medicine Guide
MOTs-C
Flagship clinician reference on MOTs-C, covering mechanism, evidence limits, metabolic signaling, and its current FDA compounding status.
PT-141 (Bremelanotide)
Melanocortin Receptor Agonist - Sexual Dysfunction Guide
Selank
Synthetic tuftsin-analog heptapeptide with anxiolytic, nootropic, and immunomodulatory properties
Semaglutide
GLP-1 Receptor Agonist - Prescriber Reference
Sermorelin
Synthetic GHRH(1-29) fragment for physiologic growth hormone optimization
TB-500
Thymosin Beta-4 Fragment - Tissue Repair Guide
Tesamorelin
GHRH Analog - FDA-Approved Growth Hormone Secretagogue
Thymosin Alpha-1
Immune-Modulating Peptide - Clinical Monograph
Tirzepatide
Dual GIP/GLP-1 Receptor Agonist - Clinical Guide
5-Amino-1MQ
Investigational metabolic and adipose-targeting agent for obesity, adipose-tissue dysfunction, and related metabolic conditions (no FDA-approved indication; no registered human clinical trials as of April 2026)
Cerebrolysin
Neurorehabilitation after ischemic stroke and traumatic brain injury (approved in 35+ countries including Austria, Germany, Russia, China; NOT FDA-approved in the United States)
Kisspeptin-10
Investigational stimulation of the hypothalamic-pituitary-gonadal (HPG) axis: diagnostic evaluation of hypogonadotropic hypogonadism, research in fertility induction, and adjunct investigation alongside testosterone replacement therapy (not FDA-approved for any indication)
KPV
Investigational anti-inflammatory therapy for inflammatory bowel disease and other chronic inflammatory conditions (no FDA-approved indication)
NAD+
Cellular energetics and mitochondrial support in age-related decline, metabolic dysfunction, and post-exertional recovery (all investigational; no FDA-approved indication for injectable NAD+)
Retatrutide
Chronic weight management and type 2 diabetes (investigational; Phase 3 TRIUMPH program ongoing. NOT FDA-approved as of April 2026)
AOD-9604 — Fat loss / Body composition
Fat loss / Body composition
BPC-157 — Gut healing
Gut healing
BPC-157 — Injury repair / Musculoskeletal
Injury repair / Musculoskeletal
Ipamorelin/CJC-1295 — Anti-aging / GH optimization
Anti-aging / GH optimization
PT-141 (Bremelanotide) — Sexual dysfunction
Sexual dysfunction
Semaglutide — Weight loss / Obesity
Weight loss / Obesity
TB-500 — Tissue repair / Wound healing
Tissue repair / Wound healing
Tesamorelin — Lipodystrophy / Visceral fat reduction
Lipodystrophy / Visceral fat reduction
503A vs 503B: Sourcing Rules for Peptides
Use 503A for named‑patient peptides and 503B for permitted office stock—always verify peptide eligibility, state law, interstate limits, and records.
Peptide Dosing Explained: Math, Units & Volume
Clear steps to calculate peptide injection volume: verify vial, compute concentration, convert dose to mL, and confirm syringe reading.
Self-Emulsifying Carriers in Oral Polypeptides
Preclinical review: self-emulsifying carriers partly protect oral peptides but do not prove systemic absorption or human dosing.
Blood-Brain Barrier Dysfunction and Early Memory Loss
Worsening memory needs clinical evaluation first; BBB tests are limited and supplements unproven—focus on cognition, risk control, and follow‑up.
Competitor Service Mapping for Peptide Clinics
Compare intake, labs, pricing, consent, and follow-up to score competitors and prioritize safe service gaps for peptide clinics.
Peptides for Sleep and Brain Recovery: Clinical Insights
Most peptides lack robust human sleep data; approved sleep drugs lead, while Cerebrolysin shows trial evidence but remains investigational.
Selank Dosing Guide: Intranasal and SubQ
Review intranasal and subcutaneous Selank dosing, administration, safety checks, and monitoring—no FDA‑approved regimen.
Sharps Containers vs Red Bags in Peptide Care
Use sharps containers for needles, red bags for regulated soft waste, and follow pharma rules in peptide clinics.
Macrophage Polarization in Gut Inflammation
Practical review of how macrophage-driven cytokines and barrier injury sustain gut inflammation, peptide prospects, and monitoring.
Peptide Overdose Reporting: Common Errors
Report suspected peptide overdoses promptly and update the case—avoid missing lot details, unclear timing, dose-math errors, missing follow-up, and delays.
Informed Consent Cases in Off-Label Prescribing
How to document informed consent, risks, FDA status, dosing, and follow-up for off‑label and compounded peptide prescribing.
4 Barriers Lipid Carriers Target in Oral Peptides
Explains four gut barriers lipid carriers must overcome for oral peptide delivery and why human exposure and safety data are essential.
POMC/CART vs NPY/AgRP: Appetite Signals
How opposing hypothalamic circuits control hunger vs satiety and what that means for peptide-based weight therapies.
Hidden Malnutrition on GLP-1: Clinical Review
Detect and monitor hidden malnutrition on GLP‑1 therapy: focus on protein, intake, body composition, targeted labs, and urgent warning signs.
GLP-1 Rechallenge After Side Effects: Guide
Safe GLP-1 restart after side effects: confirm recovery, follow product label for re-titration, start low and monitor symptoms.
Genomic Consent Templates for Clinics
Test-specific genomic consent checklist: explain results, privacy, specimen/data retention, family sharing, signatures, and follow-up.
TB-500 Dosing in Arthritis Care: Guide
No validated TB-500 arthritis dose; guidance on evidence gaps, risks, monitoring, consent, and reassessment before use.
Aseptic Technique Checklist for Peptide Visits
Step-by-step aseptic checklist for peptide injections: verify identity, prevent contamination, perform sterile prep, safe injection, disposal, and documentation
BPC-157: Acute vs Chronic Tendon Injury
No proven role for BPC-157 in acute tears or chronic tendinopathy; prioritize diagnosis, rehab, and regulatory/anti-doping checks.
7 Absolute Contraindications for Peptide Therapy
Seven product-specific stop rules for peptide therapy, with screening steps, label checks, and a pre-prescribing safety checklist.
BPC-157 Dosing Studies for Tendon Injury
An unapproved peptide shows promise in animals but lacks validated human dosing, safety, and evidence for tendon repair.
Peptide Stability in Gastric vs Intestinal Fluids
Why stomach survival doesn't guarantee oral peptide success: acid/pepsin vs broader intestinal proteases and SGF-to-SIF testing at 37°C.
Hypothalamic Peptides: Pituitary Hormone Control
Interpret pituitary labs by reading the full axis: hypothalamic signal, pituitary output, target hormones, timing, and confounders.
Why Patients Stop GLP-1 Therapy Early
Side effects, cost, refills, and weak follow-up drive early GLP‑1 drop-off—most cases are preventable with rapid assessment and system fixes.
How to Build Safer Peptide Refill Workflows
Standardize intake, chart and lab review, stop dates, and routing so staff handle peptide refills safely while prescribers retain oversight.
Informed Consent Generator
Create a clear first-draft informed consent form for therapy, wellness, and healthcare services, with practical sections and review notes.
Starting a Wellness Clinic Checklist
Build a tailored startup checklist for your wellness clinic, private practice, or holistic health business with practical next steps.
BPC-157 vs TB-500 for Bone Fracture Healing
No human proof either peptide speeds fracture healing; BPC-157 shows more animal bone data while TB-500 is largely soft-tissue.
ApoB vs Non-HDL-C in Metabolic Syndrome
Start with non-HDL-C; add apoB when triglycerides >=200 mg/dL, diabetes, or discordant lipids to assess residual ASCVD risk.
Key Peptide Terms in MOA and Biology
Master core peptide terms to predict what a peptide does, how long it lasts, and where risks arise.
Tracking Pixels on Peptide Sites: Compliance Checklist
Step-by-step HIPAA checklist to audit, classify, and remediate tracking pixels, tags, and embeds on peptide clinic websites.
Peptides vs Standard Care: When Clinicians Add Them
Add peptides only after standard care is optimized, diagnosis confirmed, evidence and product quality verified, and safe monitoring is arranged.
Peptides in Sport: Anti-Doping Study Summary
Banned peptide classes, testing limits, contamination risks, and prescribing guidance for clinicians treating tested athletes.
Local vs Systemic Peptides in Sports Rehab
Compare local vs systemic peptide delivery for sports rehab—route choice, injury patterns, accuracy, documentation, and anti-doping notes.
10 Audit Tools for Peptide Clinic Records
Checklist of 10 linked audit tools to make peptide clinic records traceable: consent, MAR, lot logs, follow-up, HIPAA, and AI EMR checks.
Vial Stopper Compatibility: Criteria and Methods
Fit-first checklist for peptide vial stoppers: seal integrity, <=10 N puncture, reseal, low coring, E&L data, and cold CCI testing.
Website Copy Checklist for Peptide Clinics
A 6-step checklist to make peptide clinic website copy clear, compliant, and easy to book—homepage, services, bios, consent, compliance, booking.
Alcohol Pads vs Swabs for Vial Prep
Choose pads for skin and flat vial stoppers, swabsticks for recessed tops; use 70% IPA, scrub with friction, and air-dry.
Brain-Gut Axis and BPC-157 in IBD
Rodent studies show BPC-157 improves gut barrier, inflammation, motility, and pain — but no FDA approval or human IBD trials.
GLP-1 vs Tirzepatide: CV Risk Beyond BMI
Compare GLP‑1 receptor agonists and tirzepatide for cardiovascular risk: outcomes vs metabolic effects and how to match therapy.
FDA MedWatch Program for Peptide Clinics
Clear clinic workflow for FDA MedWatch reporting of peptide adverse events, product defects, timing, forms, and follow-up.
Gastroparesis Risk Assessment for GLP-1 Use
Screen for gastroparesis before prescribing GLP-1s with a symptom, med, nutrition, and testing checklist plus risk-based dosing.
Telemedicine Tech Support: Pre-Visit Message Tips
Send three short pre-visit messages (booking, 24–48h, 2–4h) with a brief tech checklist, consent line, and backup call plan.
Brain Insulin Signaling in Satiety: Clinical Review
How brain insulin controls hunger and reward—human trials show short-term appetite effects but no consistent long-term weight loss.
Cross-Coverage Checklist for Peptide Follow-Up Visits
An eight-step checklist to verify indication, regimen, titration, labs, consent, and safe next steps for peptide follow-ups.
BPC-157 Safety in Practice: Prescriber Guide
Safety checklist for prescribers covering evidence limits, informed consent, pharmacy sourcing, monitoring, and athlete counseling.
Why Patients Stop GLP-1 Therapy: Q&A for Clinics
Why patients stop GLP-1s and how clinics cut drop-off: better onboarding, GI management, refill tracking, and pre-fill coverage checks.
What studies show on GLP-1 re-initiation gaps
Stopping GLP-1s often causes weight regain and worse glucose; after a gap many restart, but safer care restarts low and re-titrates slowly.
Postmarketing Reporting Programs for Peptides
Checklist for peptide clinics: intake, triage, 15-day reporting clocks, product complaints, and 10-year audit-ready records.
Closed-Loop Communication in Code Events: Guide
Assign roles, demand repeat-backs, and report completion — closed-loop communication prevents errors in high-stakes code events.
BPC-157 Mechanisms in Tendon Injury Models
Preclinical tendon models consistently show angiogenesis, cell migration, and matrix remodeling signals—but no human efficacy or dosing proof.
Standing Order Workflow: Team Care Analysis
Compare four standing-order workflows for peptide care and essential checklists for labs, consent, stop rules, and escalation.
Lyophilized Peptides: Light, Humidity, Storage
Clinic guide to storing lyophilized peptides: prevent light, moisture, and temperature swings; use amber vials, desiccant, and label reconstituted doses.
Peptide Injection Workspace Checklist
Five-step at-home peptide injection checklist: clean surface, wash and dry hands, confirm vial, match syringe, keep a sharps container.
Peptide Transport Across Blood-Testis Barrier
Whole-testis levels mislead: true peptide passage requires intact BTB evidence, transporter localization, and intratubular sampling.
Why GH Peptides May Curb GLP-1 Muscle Loss
Explains how GH secretagogues might protect lean mass during GLP‑1 weight loss, but RCTs and functional benefits are lacking.
7 RUO Peptide Compliance Checks for Clinics
Seven checks clinics must run to keep RUO peptides out of patient care: vendor, labels, storage, policies, charts, training, legal.
DSIP for Brain Recovery: Clinical Review
DSIP remains investigational with weak human evidence for brain injury recovery—prioritize CBT‑I, melatonin, and standard rehab.
Peptide vs Excipient Allergy: Key Differences
Distinguish peptide from excipient injection reactions by timing, recurrence across lots, excipient lists, and targeted testing.
5 Peptides Targeting Intestinal Cytokine Signaling
Review of five investigational peptides that modulate gut cytokine and barrier pathways; one has phase II UC data.
Guide to Brand Positioning for Pain Clinics
Position a pain clinic around one patient problem, clear functional goals, and transparent peptide use across care.
Influencer Campaign Metrics for Medical Practices
Measure influencer ROI by consults booked, new patients, and CAC—use UTMs, referral codes, booking rates, LTV, and HIPAA-safe tracking.
How to Respond to Negative Patient Reviews
HIPAA-safe steps to triage, draft, and post neutral replies to negative patient reviews—avoid PHI, move issues offline, and log outcomes.
When Peptide Dose Escalation Makes Sense
Raise peptide doses only after adequate time, measurable partial response, acceptable side effects, and verified adherence.
Liraglutide and GLUT4: Muscle Glucose Uptake
Preclinical data suggest GLP-1 agonists enhance GLUT4 trafficking in insulin-resistant muscle, yet direct human muscle evidence is lacking.
7 Studies on Epitalon, Aging, and Telomeres
Review finds strong cell-level effects, mixed animal results, and weak human evidence—Epitalon remains investigational.
Brown Fat Activation Peptides: 4 Mechanisms
Four peptide-linked routes to activate brown fat - UCP1, mitochondrial heat, browning, and endocrine crosstalk - with modest clinical impact.
Counterfeit Peptides: Risk Review for Prescribers
Guidance for clinicians to verify peptide sources, confirm CoA/sterility, document lots, and stop use when records are missing.
GLP-1 Peptides and Insulin-Mediated Glucose Uptake
GLP‑1 peptides lower glucose mainly via glucose‑dependent insulin, glucagon suppression, and slower gastric emptying; direct muscle uptake in humans is limited.
How to Interpret Peptide Research for Clinical Use
Clinical guide to evaluate peptide evidence, regulatory status, safety, dosing, and sourcing for responsible patient use.
Best Practices for Intramuscular Injection Angles
Practical guide to true 90° IM insertion, correct needle length, site landmarks, Z‑track, and special-population adjustments.
Oxytocin Dosing for Social Impairments
Oxytocin dosing must be matched to patient and study design; 24 IU is the common benchmark, 48 IU shows pooled benefit, and sodium monitoring is essential.
How Peptides Target Cardiovascular Tissues
How peptides plus carrier systems concentrate drugs in heart or vessel lesions—benefits, limits, safety, and clinical checks.
Regulatory Guidelines for Adverse Event Logs
How peptide clinics should log, classify, escalate, and report adverse events to meet FDA timelines and retain records for 10 years.
Tumor-Targeting Peptides: Mechanisms of Action
How tumor-targeting peptides locate tumors, cross barriers, enter cells, and act via targeting, microenvironment activation, trafficking, or drug delivery.
Bioactive Peptides in Lipid Regulation: Key Insights
Review of soy, marine, algae, and animal peptides for cholesterol, triglyceride, and liver-fat control; soy has strongest clinical evidence.
Niche Branding for Regenerative Medicine Clinics
Brand around one patient problem—not a peptide—to improve clarity, ad compliance, patient trust, and recurring revenue.
Common Drug Interactions in Weight Loss Peptides
Peptide weight-loss drugs slow gastric emptying; watch hypoglycemia with diabetes meds, reduced oral contraceptive effect, and thyroid/INR shifts.
Endotoxin Testing Regulations: What Prescribers Need to Know
How prescribers should verify endotoxin limits, COA data, and pharmacy type (503A/503B) before using compounded injectable peptides.
Top 5 Tools for Peptide Batch Calculations
Compare five essential tools for precise peptide reconstitution and dosing: clinical calculators, spreadsheets, apps, pharma tools, and syringe converters.
How Peptides Affect Appetite and Satiety Signals
How gut peptides communicate with the brain to drive hunger and fullness, and how peptide therapies alter appetite and support weight loss.
Peptide Dosing Protocols for Post-Surgery Healing
Guidelines for using BPC-157 and TB-500 after surgery: timing, dosing, safety, and monitoring.
Peptide Delivery Systems: Skin-Specific Innovations
Compare liposomes, hydrogels, microneedles and iontophoresis for safe, targeted peptide delivery across the skin barrier.
Peptide Reconstitution Errors: Causes and Fixes
Avoid peptide dosing, solvent, technique, and storage errors with clear reconstitution steps, calculators, and SOP tips.
Peptides for Brain Fog: Mechanisms of Action
Explains how peptides relieve brain fog via anti-inflammatory, mitochondrial, neurotransmitter and vascular mechanisms, plus delivery and safety.
Peptide Dosing: Avoiding GI Side Effects
Start low, titrate slowly, and use diet and hydration to prevent nausea, diarrhea, and constipation during peptide therapy.
Top 7 Trends in Sustainable Peptide Manufacturing
Seven practical trends—renewable materials, greener solvents, energy-efficient synthesis, safer chemistries, and AI—cutting waste in peptide production.
Lab Tests for Evaluating Peptide Therapy Results
Baseline, follow-up, and periodic labs (IGF-1, CMP, CBC, glucose) to safely monitor and adjust peptide therapy.
AI in Peptide Therapy: Benefits and Challenges
How AI speeds peptide therapy research, dosing, and risk checks—boosting efficiency while requiring clinician verification and regulatory vigilance.
Chondroinductive Peptides: Clinical Applications
Overview of chondroinductive peptides for cartilage regeneration: mechanisms, delivery strategies, clinical trials, and translational hurdles.
Emerging Gut-Brain Peptides for Obesity
Overview of multi-agonist gut-brain peptide therapies for obesity, including trial outcomes, mechanisms, and safety considerations.
Ultimate Guide to Peptide Therapy Conferences
Practical guide to choosing, preparing for, and applying insights from peptide therapy conferences for clinicians and researchers.
How to Build a Peptide Protocol for Metabolic Patients
Clinician-led steps to select, dose, monitor, and combine peptides for obesity, type 2 diabetes, and metabolic syndrome.
Peptide Therapy FAQs: Answers for Licensed Prescribers
Practical FAQ for licensed prescribers on patient selection, dosing, safety, and FDA compounding rules for peptide therapy.
Top Peptide Research Updates for Clinicians: 2026 Roundup
2026 clinical summary of peptide advances across weight loss, regeneration, cognition, aesthetics, and immunomodulation.
CJC-1295 vs Ipamorelin: Which GHRH Protocol Fits Best?
Pairing a short-acting GHRH analogue with a ghrelin agonist yields physiological GH pulses that boost recovery, sleep, and body composition.
Peptide Therapy Prescribing Checklist for New Clinicians
Clear checklist for clinicians covering patient evaluation, labs, legal sourcing, dosing, and monitoring of peptide therapies.
Compounded Peptides: Navigating FDA Compliance in 2026
2026 FDA updates tighten rules for compounded peptides: clinical-need documentation, 503A/503B limits, API sourcing, and PCAC reviews.
How to Counsel Patients on Peptide Injection Technique
Practical guidance on safe peptide injections: dosing math, reconstitution, storage, site rotation, and sharps disposal.
Semaglutide vs Tirzepatide: Clinical Comparison for Prescribers
Two weekly incretin therapies differ in weight, glycemic control, and long-term safety—prescribe based on cardio‑renal needs vs maximal weight loss.
8 Peptide Therapies Gaining Traction in Functional Medicine
Overview of eight peptides used in functional medicine: mechanisms, uses, dosing, and safety considerations.
Understanding Peptide Therapy: A Clinical Overview for Prescribers
A comprehensive introduction to peptide therapeutics, their mechanisms of action, and clinical considerations for integration into practice.
Regulatory Landscape: What Prescribers Need to Know About Compounded Peptides
Navigate the complex regulatory environment surrounding compounded peptides, including FDA guidelines, state requirements, and best practices for compliance.
Patient Selection Criteria for Peptide Therapy
Evidence-based guidance on identifying appropriate candidates for peptide therapeutics, including assessment protocols and contraindication screening.
Medical Disclaimer
This search tool is provided as an educational resource for healthcare professionals. Search results are drawn from curated clinical content and should not replace professional medical judgment. Always verify information with primary sources and current clinical guidelines.